Add 2 More Reports For 20% off

Report Overview

The global haemato oncology testing market is forecast to reach USD 9.47 billion by 2034 from USD 2.81 billion in 2024, growing at a CAGR of 14.6% over the forecast period of 2025-2034.

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Global Haemato Oncology Testing Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Haematological malignancies are among the top ten malignant disorders in terms of incidence rate and cause of death in cancer patients. They collectively make up about 9% of all cancer cases diagnosed in a year. Geneticists provide not only diagnostic tests to haemato oncologists, but also key knowledge of cancer genetics that helps the specialists evaluate their patient’s prognosis, select the most appropriate anticancer therapy, and monitor treatment response.

Market Segmentation

Haemato oncology testing is a test that aids in the diagnosis of blood disease (haematology) and cancer (oncology), further supporting the treatment and prevention of the disease, and providing research into them. Haematology-oncology includes diseases such as iron deficiency anaemia, haemophilia, sickle cell disease, thalassemia, leukaemia, and other organ cancers. The haemato oncology testing industry can be divided based on segments like cancer type, technology, and application.

Market Breakup by Cancer Type

  • Laeukemia
  • Lymphoma
  • Hodgkin Lymphoma
  • Others

Market Breakup by Technology

  • PCR
  • IHC
  • NGS
  • Cytogenetics
  • Others

Market Breakup by Application

  • Clinical Laboratories
  • Hospitals
  • Academic and Research Institutes
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Haemato Oncology Testing Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis

The global haemato oncology testing market is driven by haematological cancer’s increasing global prevalence, increasing awareness of personalized medicines, and increasing collaborations to develop new assays. On the other hand, it is expected that an uncertain reimbursement scenario will restrict the growth of this market during the forecast period in various regions.

Global Haemato Oncology Testing Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The services segment represents the largest proportion of haemato oncology testing. This is mainly due to the growing prevalence and incidence of leukaemia, non-Hodgkin lymphoma, and cancer of myeloma. In addition, the growing awareness of advanced therapies such as personalized medicine also drives this segment’s growth. The growth in the Asia Pacific market is driven primarily by the large patient population, and a growing focus on expanding in this region will drive the industry growth.

Competitive Landscape

The report presents a detailed analysis of the following key players in the global haemato oncology testing market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche Ltd. [Roche Holding AG]
  • Abbott Laboratories
  • Qiagen N.V
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • ICON plc
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2023, the global haemato oncology testing market attained a value of nearly USD 2.81 billion.

The market is projected to grow at a CAGR of 14.6% between 2024 and 2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 9.47 billion by 2032.

The major drivers expected to aid the market growth are the increasing prevalence of haematologic cancer, rising awareness regarding advanced therapies for cancer treatment, preference for personalised medical solutions, improving health care facilities, and growing technological advancements. 

The key trends guiding the growth of the market include advancements in diagnostics and testing solutions, growing collaborations and research and development activities, and the development of real time assay kits. 

The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Leukaemia, Lymphoma, and Hodgkin Lymphoma, among others, are the major cancer types in the market.

PCR, IHC, NGS, and cytogenetics, among others, are the significant haemato oncology testing technologies available in the market.

Clinical laboratories, hospitals, and academic and research institutes, among others, are the leading applications of the product in the market.

The key players in the global haemato oncology testing market are  F. Hoffmann-La Roche Ltd., Abbott Laboratories, Qiagen N.V, Thermo Fisher Scientific Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., and ICON plc, among others.

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Cancer Type
  • Technology
  • Application
  • Region
Breakup by Cancer Type
  • Laeukemia
  • Lymphoma
  • Hodgkin Lymphoma
  • Others
Breakup by Technology
  • PCR
  • IHC
  • NGS
  • Cytogenetics
  • Others
Breakup by Application
  • Clinical Laboratories
  • Hospitals
  • Academic and Research Institutes
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • F. Hoffmann-La Roche Ltd. [Roche Holding AG]
  • Abbott Laboratories
  • Qiagen N.V
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • ICON plc
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124